SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Aug-24 4:56 PM View: | Lantheus Holdings, Inc. (LNTH) | 12-Aug-24 | Private Sale (Planned) | 15,500 | $96.48 | $1,495,400.00 | (42%) 36.72K to 21.22K | |
11-Jun-24 7:54 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 10-Jun-24 | Sale | 722 | $12.00 | $8,664.00 | (31%) 2.33K to 1.61K | |
15-May-24 4:30 PM View: | Lantheus Holdings, Inc. (LNTH) | 13-May-24 | Payment of Exercise | 302 | $77.88 | $23,519.80 | (< 1%) 37.02K to 36.72K | |
13-May-24 5:11 PM View: | Lantheus Holdings, Inc. (LNTH) | 09-May-24 | Grant | 2,635 | -- | -- | 8% 34.72K to 37.35K | |
09-Jun-23 6:02 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 08-Jun-23 | Grant | 2,330 | -- | -- | 100% 0 to 2.33K | |
15-May-23 6:35 PM View: | Lantheus Holdings, Inc. (LNTH) | 11-May-23 | Grant | 2,012 | -- | -- | 6% 32.7K to 34.72K | |
15-May-24 4:30 PM View: | Lantheus Holdings, Inc. (LNTH) | 08-May-23 | Payment of Exercise | 327 | $94.82 | $31,006.10 | (< 1%) 37.35K to 37.02K | |
12-May-22 5:25 PM View: | Lantheus Holdings, Inc. (LNTH) | 10-May-22 | Private Sale | 1,277 | $58.19 | $74,308.60 | (4%) 33.98K to 32.7K | |
10-May-22 4:39 PM View: | Lantheus Holdings, Inc. (LNTH) | 06-May-22 | Grant | 2,180 | -- | -- | 7% 31.8K to 33.98K | |
12-May-21 4:30 PM View: | Lantheus Holdings, Inc. (LNTH) | 10-May-21 | Grant | 8,513 | -- | -- | 37% 23.29K to 31.8K | |
05-Oct-20 4:50 PM View: | Lantheus Holdings, Inc. (LNTH) | 01-Oct-20 | Grant | 1,065 | -- | -- | 5% 22.22K to 23.29K | |
12-Aug-20 5:39 PM View: | Lantheus Holdings, Inc. (LNTH) | 10-Aug-20 | Grant | 741 | -- | -- | 3% 21.48K to 22.22K | |
23-Jun-20 4:48 PM View: | Progenics Pharmaceuticals I... (PGNX) | 19-Jun-20 | Disposition | 50,000 | -- | -- | (100%) 50.0K to 0 | |
23-Jun-20 5:21 PM View: | Lantheus Holdings, Inc. (LNTH) | 19-Jun-20 | Grant | 21,481 | -- | -- | 100% 0 to 21.48K |